P/87/2010
Submitted by Anonymous (not verified) on 6 February 2025 - 11:28
P/87/2010
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes
Submitted by Anonymous (not verified) on 5 February 2025 - 16:46
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
Submitted by Anonymous (not verified) on 5 February 2025 - 16:45
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
PSUSA/00002229/202404
Submitted by Anonymous (not verified) on 5 February 2025 - 15:40
PSUSA/00002229/202404
EMEA-001434-PIP01-13-M03
Submitted by Anonymous (not verified) on 5 February 2025 - 15:39
EMEA-001434-PIP01-13-M03
PSUSA/00010774/202403
Submitted by Anonymous (not verified) on 5 February 2025 - 15:35
PSUSA/00010774/202403
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Submitted by Anonymous (not verified) on 5 February 2025 - 15:22
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Date of authorisation: 15/11/2021, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 5 February 2025 - 15:08
Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Date of authorisation: 15/11/2021, Revision: 8, Status: Authorised
Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings
Submitted by Anonymous (not verified) on 5 February 2025 - 14:00
Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings
Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn
Submitted by Anonymous (not verified) on 5 February 2025 - 13:42
Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn